Skip to main content

Zimmer Biomet Holdings Value Stock - Dividend - Research Selection

Zimmer

ISIN: US98956P1021 , WKN: 753718

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through four segments: Spine, less Asia Pacific; Office Based Technologies; Craniomaxillofacial and Thoracic; and Dental. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including surgical, sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products; and bone cement and spinal fusion stimulators. The company\'s products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopaedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Intuitive Surgical Stock Has Fallen While Its Operating Margin Keeps Widening

2026-08-21
With US procedure growth slowing and the shares well below their high, the operating margin has widened in each of the last three years.

Is Zimmer Biomet Stock Worth Retaining in Your Portfolio Now?

2026-08-20
ZBH's growth outlook is backed by healthy procedure demand and Z1, HAMMR and OrthoGrid adoption, though debt and competition remain concerns.

Stryker: The Sell-Off Creates A Better Entry Point, But Q2 Wasn't Perfect

2026-08-20
Stryker (SYK) rebounds with 9% organic growth in Q2 as key segments accelerate.

Enovis: Executing Better, But Still Remains Stuck In A Med-Tech No Man's Land

2026-08-20
Enovis is gaining share in joint reconstruction, leveraging new products and capitalizing on competitor disruptions. Learn more about ENOV stock here.

Zimmer Biomet (ZBH) Stock Still Looks Discounted After a 28% Five Year Slide

2026-08-20
Zimmer Biomet Holdings has seen its share price decline about 27.9% over the past five years, yet the stock still screens as attractively priced on several valuation checks. This raises questions for investors trying to reconcile weak long term returns with a more positive current valuation read. Over the past five years the stock has declined about 27.9%, which signals that long term holders have not yet been rewarded despite the recent rebound. The ongoing shift to a fully dedicated sales...

Disappointing Ortho Performance Continues To Hold Smith & Nephew Back (Downgrade)

2026-08-19
Smith & Nephew stock is downgraded to 'Hold' amid weak orthopedics, a guidance cut, and exec turnover. Here's what you need to know about SNN.

Is ISRG's Software Strategy Becoming as Important as Its Robots?

2026-08-18
ISRG's software roadmap is strengthening da Vinci 5, with new features, renewals and recurring service revenues reinforcing its digital ecosystem.

Stryker Corporation: Hold For Quality, Wait For The Dip

2026-08-18
Stryker is a MedTech compounder with 11% organic revenue growth and expanding margins. Click here to read why SYK stock is a Hold.

AM Applications Analysis: Parts Produced 2025-2034 Delivers 10-Year Additive Manufacturing Market Forecast

2026-08-17
Supported by real market data through Q4 2025 and 10-year projections, this study delivers a granular evaluation across metal and polymer part categories (prototypes, tooling, end-use production components) and major consuming end-markets, including aerospace giants (GE Aerospace, SpaceX, BAE Systems), medical leaders (Stryker, Zimmer Biomet, Align Technologies), and automotive/tech pioneers (Tesla, Apple, Nvidia).Dublin, Aug. 17, 2026 (GLOBE NEWSWIRE) -- The "AM Applications Analysis: Parts Pro

SYK Stock Gains 3.8% Since March-End: What's Driving the Uptrend?

2026-08-14
Stryker has gained 3.8% since March-end as Mako robotics, hospital capital demand and international growth drive momentum.